| 000 | 01852 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516172930.0 | ||
| 264 | 0 | _c20140804 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1989-2284 | ||
| 024 | 7 |
_a10.3265/Nefrologia.pre2013.Apr.12027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalma-Barrio, Ramiro | |
| 245 | 0 | 0 |
_aInfection due to Pneumocystis jirovecii in haemodialysis. _h[electronic resource] |
| 260 |
_bNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _c2013 |
||
| 300 |
_a742-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xcomplications |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCandidiasis _xcomplications |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xcomplications |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPneumocystis carinii _xisolation & purification |
| 650 | 0 | 4 |
_aPneumonia, Pneumocystis _xetiology |
| 650 | 0 | 4 |
_aPostoperative Complications _xetiology |
| 650 | 0 | 4 |
_aPyelonephritis _xcomplications |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aSuperinfection _xetiology |
| 700 | 1 | _aTorres-de Rueda, Álvaro | |
| 700 | 1 | _aPizarro-León, José L | |
| 773 | 0 |
_tNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _gvol. 33 _gno. 5 _gp. 742-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3265/Nefrologia.pre2013.Apr.12027 _zAvailable from publisher's website |
| 999 |
_c23137399 _d23137399 |
||